Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
20.17
-6.50 (-24.37%)
At close: Mar 28, 2025, 4:00 PM
20.04
-0.13 (-0.64%)
After-hours: Mar 28, 2025, 7:59 PM EDT
TNXP Employees
Tonix Pharmaceuticals Holding had 103 employees as of December 31, 2023. The number of employees decreased by 14 or -11.97% compared to the previous year.
Employees
103
Change (1Y)
-14
Growth (1Y)
-11.97%
Revenue / Employee
$98,000
Profits / Employee
-$1,262,485
Market Cap
129.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TNXP News
- 2 days ago - Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - GlobeNewsWire
- 4 days ago - Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha
- 4 days ago - Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 5 days ago - Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia - GlobeNewsWire
- 9 days ago - As Mpox Cases Spread Around the World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread - Accesswire
- 10 days ago - Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 11 days ago - Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 16 days ago - Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025 - GlobeNewsWire